WallStreetZenWallStreetZen

NASDAQ: ITRM
Iterum Therapeutics PLC Stock Ownership - Who owns Iterum Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Iterum Therapeutics PLC insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Michael W. DunneDirector2023-12-2225,000$1.40
$35.00kBuy
Michael W. DunneDirector2023-12-1810,000$1.84
$18.44kBuy
Sailaja PuttaguntaChief Medical Officer2023-12-012,933$2.12
$6.22kSell
Michael W. DunneDirector2023-11-2220,000$2.03
$40.68kBuy
Corey N. FishmanChief Executive Officer2023-11-2010,000$1.59
$15.86kBuy

1 of 1

ITRM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ITRM insiders and whales buy or sell their stock.

ITRM Shareholders

What type of owners hold Iterum Therapeutics PLC stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP70.93%11,651,597$18.06MInsider
Brenton Karl Ahrens10.55%1,733,580$2.69MInsider
Canaan X LP10.55%1,733,170$2.69MInsider
James Healy10.55%1,732,668$2.69MInsider
Patrick J. Heron9.42%1,547,322$2.40MInsider
Vijay K. Lathi8.87%1,456,303$2.26MInsider
Sofinnova Venture Partners Ix LP7.47%1,226,514$1.90MInsider
Shahzad Malik5.29%868,161$1.35MInsider
Apollon Financial LLC1.22%200,000$310.00kInstitution
Michael W. Dunne0.69%113,754$176.32kInsider

1 of 3

ITRM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ITRM1.70%98.30%Net Buying
PLUR0.58%99.42%
GDTC0.04%57.45%
SNSE11.82%71.99%Net SellingNet Selling
UBX25.70%51.52%Net SellingNet Selling
View Top Biotech Stocks

Iterum Therapeutics Stock Ownership FAQ

Who owns Iterum Therapeutics?

Iterum Therapeutics (NASDAQ: ITRM) is owned by 2.35% institutional shareholders, 136.08% Iterum Therapeutics insiders, and 0.00% retail investors. Ra Capital Management LP is the largest individual Iterum Therapeutics shareholder, owning 11.65M shares representing 70.93% of the company. Ra Capital Management LP's Iterum Therapeutics shares are currently valued at $18.29M.

If you're new to stock investing, here's how to buy Iterum Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.